Abstract: New physiologically active substances, ebelactone A and ebelactone B which are generally termed ebelactone are produced from a new microorganism, Streptomyces MG7-G1 strain identified FERM-P 5363 or ATCC No. 31860 and ATCC No. 31880. Ebelactone is useful as a host defense stimulator having an activity to enhance cell-mediated immunity, and also as an anti-inflammatory agent.
Type:
Grant
Filed:
March 4, 1981
Date of Patent:
November 9, 1982
Assignee:
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kao